This case suggests a potential Ridaq Death side effect(s) that can have serious consequences. A 59-year-old patient from SOUTH AFRICA (weight:NA) was diagnosed with the following health condition(s): hypertension,metastatic renal cell carcinoma and used Ridaq (dosage: 5 Mg, 1x/day) starting Oct 20, 2011. Soon after starting Ridaq the patient began experiencing various side effects, including:
Drugs used concurrently:Axitinib (5 Mg, 2x/day)
Enalapril (20 Mg, 1x/day)
Doxycycline Calcium (100 Mg, 2x/day)
Although Ridaq demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
Adverse event was reported on Feb 09, 2012 by a Female taking Ridaq (Dosage: 12.5 Milligram) . Location: SOUTH AFRICA , 51 years of age, weighting 231.5 lb, Directly after treatment started, patient experienced the unwanted or unexpected Ridaq side effects: haematemesis.
Associated medications used:
- Metformin Hcl (1700 Milligram)
- Adalat Cc (30 Milligram)
- Azacitidine (75 Microgram/sq. Meter)
- Gliclazide (500 Milligram)